Big Facility for Diabetes Patients: American scientists have developed such an insulin. After injecting insulin once a week, there will be no need to inject again and again. This injection and its dose have been found to be successful in clinical trials.
By taking insulin called Epistora Alpha once a week, type one and type two sugar can be controlled for the whole week.
The results of two phase I insulin trials were presented at the European Association for the Study of Diabetes meeting in Madrid.
It was found to be safe for type 1 and type 2 diabetes patients.
In the clinical trial, 928 patients of type 2 diabetes and 623 patients of type 1 diabetes were included. The clinical trial continued for 52 consecutive weeks.
It has been found to be safe for type one and type two diabetes patients. Now there will be no need to take insulin injections daily. One injection will be enough for a week. Diabetes patients will get a lot of relief from this.
